StockNews.com upgraded shares of Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) from a hold rating to a buy rating in a research note published on Monday. A number of other equities research analysts also recently issued reports on the company. Barclays cut their price target on Amneal Pharmaceuticals from $7.00 to $4.00 and set an overweight […]
StockNews.com upgraded shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. Amneal Pharmaceuticals Stock Performance Shares of AMRX opened at $1.88 on Tuesday. Amneal Pharmaceuticals has a 12 month low of $1.24 and a 12 month high of $3.77. The company has […]
500.com reiterated their maintains rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) in a research report released on Monday morning, Benzinga reports. AMRX has been the topic of a number of other research reports. BMO Capital Markets dropped their price target on Amneal Pharmaceuticals from $5.00 to $4.00 and set a market perform […]
StockNews.com upgraded shares of Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) from a hold rating to a buy rating in a report published on Monday. Several other equities research analysts also recently commented on AMRX. Truist Financial dropped their price objective on shares of Amneal Pharmaceuticals from $5.00 to $4.00 and set a buy rating on […]
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) had its target price trimmed by Piper Sandler from $5.00 to $3.00 in a research note published on Monday morning, The Fly reports. Other analysts also recently issued research reports about the stock. StockNews.com initiated coverage on shares of Amneal Pharmaceuticals in a report on Friday, March 17th. They […]